Home/Filings/4/0001209191-23-008384
4//SEC Filing

Lind Kevin Robert 4

Accession 0001209191-23-008384

CIK 0001832168other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:27 PM ET

Size

5.3 KB

Accession

0001209191-23-008384

Insider Transaction Report

Form 4
Period: 2023-02-09
Lind Kevin Robert
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-09+325,850325,850 total
    Exercise: $4.35Exp: 2033-02-08Voting common stock (325,850 underlying)
Footnotes (1)
  • [F1]The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.

Issuer

Longboard Pharmaceuticals, Inc.

CIK 0001832168

Entity typeother

Related Parties

1
  • filerCIK 0001677036

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:27 PM ET
Size
5.3 KB